drugset / Trial / NCT06888128
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
Phase 2
Recruiting
15 enrolled
Baylor College of Medicine
AIM Youth Mental Health · collabTexas Department of State Health Services · collabUsona Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
The principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, and clinical efficacy of psilocybin-assisted therapy for the treatment of PTSD in US Veterans.
Timeline
- Start
- 2025-01-30
- Primary completion
- 2026-12-15
- Completion
- 2026-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 15 mg | — |
| Subject | Psilocybin | Other / unclassified | 25 mg | — |